112 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
of its capital stock, (ii) there has not been any material change in the capital stock or long-term or short-term debt of the Company or its … thereto), there shall not have been any change in the capital stock or long-term or short-term debt of the Company or the Subsidiaries or any change
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
and sought continued treatment with DCCR were eligible to receive DCCR in a long-term open-label safety extension Study (C602). Top line results from DESTINY … observed in two of three key secondary endpoints. Subjects who complete the DESTINY PWS study were allowed to enroll in a long-term, safety extension
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
treatment with DCCR were eligible to receive DCCR in a long-term open-label safety extension Study (C602). Top line results from DESTINY PWS were … in two of three key secondary endpoints. Subjects who complete the DESTINY PWS study were allowed to enroll in a long-term, safety extension study (C602
8-K
EX-99.1
i6gg0ka0p9zxk
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
S-3ASR
kc1 7l0f3etwro9o2v4
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-1.1
p9hqwgk i0ns8x15f253
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
i7tmv5k079sfo1wz
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
7yzw6 fstgdom3hl
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
f1458p6fivl jkg
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
lf61yx sny
26 Sep 23
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from
7:30am
8-K
EX-99.1
1hykrg 04mb
8 Aug 23
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:25pm